ACRX : Summary for AcelRx Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 5 hrs 6 mins

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.60+0.05 (+1.96%)
At close: 4:00PM EDT
People also watch
ALIMAVEOECYTAEGRINFI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.55
Open2.60
Bid2.05 x 100
Ask0.00 x
Day's Range2.55 - 2.65
52 Week Range2.40 - 4.08
Volume150,539
Avg. Volume205,509
Market Cap117.87M
Beta2.85
PE Ratio (TTM)-2.73
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • AcelRx Pharmaceuticals to Hold First Quarter 2017 Financial Results Conference Call and Webcast on Monday, May 8th, 2017
    PR Newswire21 hours ago

    AcelRx Pharmaceuticals to Hold First Quarter 2017 Financial Results Conference Call and Webcast on Monday, May 8th, 2017

    REDWOOD CITY, Calif., April 26, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, today announced that it will release First Quarter financial results after market close on Monday, May 8th, 2017. AcelRx management will host an investment-community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on May 8th, 2017 to discuss the financial results and provide a corporate update. Investors who wish to participate in the conference call may do so by dialing (866) 361-2335 for domestic callers, (855) 669-9657 for Canadian callers or (412) 902-4204 for international callers.

  • AcelRx Pharmaceuticals Reports Publication of Manuscripts Analyzing IV, Transdermal and Sublingual Patient-Controlled Analgesia Systems
    PR Newswire14 days ago

    AcelRx Pharmaceuticals Reports Publication of Manuscripts Analyzing IV, Transdermal and Sublingual Patient-Controlled Analgesia Systems

    REDWOOD CITY, Calif., April 13, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies ...

  • Capital Cube16 days ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : April 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)